HA
SZYM

Hamel Associates’s SOLAZYME INC COM STK (DE) SZYM Stock Holding History

Hamel Associates’s Portfolio SZYM Stock Details SZYM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-10,000
Closed -$109K – 96
2013
Q4 		$109K Buy
+10,000
New +$98.4K 0.08% 93

Other funds holding SZYM

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
PC
Passport Capital San Francisco, California $394M AUM 50.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
WF
Welch & Forbes Boston, Massachusetts $7.73B AUM 14.94% 1-Year Est. Return

Hamel Associates's SZYM Position: Q1 2014 in Review

Hamel Associates sold out of SOLAZYME INC COM STK (DE) (SZYM) in Q1 2014, closing a stake of 10,000 shares — an estimated $109K sold.

Hamel Associates first reported a position in SZYM in Q4 2013 and held it in 1 quarter. The position peaked at $109K in Q4 2013. 122 funds tracked by Wall St. Rank hold SZYM as of Q1 2014.

  • Hamel Associates reported no remaining SOLAZYME INC COM STK (DE) position as of Q1 2014 after selling out during the quarter.
  • Hamel Associates sold 10,000 SOLAZYME INC COM STK (DE) shares in Q1 2014, an estimated $109K.
  • Hamel Associates first reported a position in SOLAZYME INC COM STK (DE) in Q4 2013 and held it in 1 quarter.
  • Hamel Associates's SOLAZYME INC COM STK (DE) position peaked at $109K in Q4 2013.
  • 122 funds tracked by Wall St. Rank held SOLAZYME INC COM STK (DE) as of Q1 2014.

Based on Hamel Associates's 13F filing for Q1 2014, filed 13 May 2014.